Tag: investigational vaccine candidates (BNT162b1 and BNT162b2)
Pfizer & Biontech announce agreement with Britain for 30 million doses...
Pfizer and BioNTech remain on track to begin an anticipated Phase 2b/3 safety and efficacy trial later this month, seek regulatory review as early...